VIVO OPPORTUNITY, LLC sold 13.1% of their position (1.10M shares) of SOLENO THERAPEUTICS INC on the open market
Open‑market sale worth $51.70M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 5/1/2024ACC: 0001213900-24-038343
10% Owner
Since May 2023
-1.10M
Net shares
Net seller
$51.70M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
1.10M disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−750K
Price / share
$47.80
Trade value
$35.85M
% of position
8.9%
4/29/2024
8.42M→7.67M
Common Stock
Indirect
Shares
−351.24K
Price / share
$45.13
Trade value
$15.85M
% of position
4.6%
4/30/2024
7.67M→7.32M
Total
Net shares
−1.10M
Net value
-$51.70M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 4/29/2024 | S · Sale | −750K | $47.80 | $35.85M | 8.9% | 8.42M | 7.67M |
| Common Stock Indirect | 4/30/2024 | S · Sale | −351.24K | $45.13 | $15.85M | 4.6% | 7.67M | 7.32M |
| Total | −1.10M | -$51.70M | ||||||
Derivative Transactions0
No derivative transactions reported